Lung cancer cells have differential signalling responses to KRAS inhibitor treatment
Genetic alterations of the KRAS gene are some of the most common mutations in lung…
Browsing: KRAS
How genes and environment conspire in pancreatic cancer development discovered
Like weeds sprouting from cracks in the pavement, cancer often forms in sites of tissue…
Scientists develop new drug that targets pathway found in several hard-to-treat cancers
After decades of no luck, scientists have finally found a way to target the KRAS…
Potential treatment for an aggressive form of lung cancer
Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI), USA, have discovered…
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers
A new drug designed to counter the effects of an important, but very hard to…
Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumours
New results from early clinical trials of a drug that targets a cancer-causing mutation in…
Update on Genetic Testing in Cancer and Targeted Therapy
Cancer, a leading cause of mortality, is associated with aberrant genes. Many of the most…
Drug that targets key mutation found to shrink some tumours
A team of researchers affiliated with several institutions in the U.S. and Australia has found…
Same but different: Unique cancer traits key to targeted therapies
Melbourne researchers have discovered that the key to personalised therapies for some types of lung…
Study points to new strategy for boosting immunotherapy effectiveness in advanced colorectal cancer
Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS…